Cefprozil

Product NDC: 42043-262
11-digit product format: 420430262
Labeler code: 42043
Product ID: 42043-262_0adde9cc-25aa-4535-acb3-f1e73825933c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefprozil
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: OrchidPharma Inc
Application: ANDA065284
Marketing category: ANDA
Marketing start: 2015-08-19
Marketing end: 2019-11-30
Substance: CEFPROZIL
Active strength: 125 mg/5mL
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42043-262		D	Discontinued by firm	2026-08-17
excluded package	package	42043-262	42043-262-38	D	Discontinued by firm	2026-08-17
excluded package	package	42043-262	42043-262-57	D	Discontinued by firm	2026-08-17
excluded package	package	42043-262	42043-262-77	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42043-262-77	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42043-262-38	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42043-262-57	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42043-262-77	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42043-262-38	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42043-262-57	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42043-262-77	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42043-262-38	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42043-262-57	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42043-262-77	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42043-262-38	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42043-262-57	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42043-262-77	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42043-262-38	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42043-262-57	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42043-262-77	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42043-262-38	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42043-262-57	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42043-262-77	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42043-262-38	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42043-262-57	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42043-262-77	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42043-262-38	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42043-262-57	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42043-262-77	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42043-262-38	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42043-262-57	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42043-262-77	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42043-262-38	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42043-262-57	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42043-262-77	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42043-262-38	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42043-262-57	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42043-262-77	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42043-262-38	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42043-262-57	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065284-001	CEFPROZIL	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL			2005-12-30
A065284-002	CEFPROZIL	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL			2005-12-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL		2005-12-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065284-001	CEFPROZIL	250MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065284-002	CEFPROZIL	125MG/5ML	FOR SUSPENSION / ORAL	AB	2005-12-30	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-04-04 05:41 UTC	2022-04	A065284-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065284-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065284-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065284-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065284-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065284-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065284-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065284-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065284-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065284-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065284-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065284-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065284-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065284-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065284-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065284-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065284-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065284-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065284-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065284-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065284-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065284-002	AB	1	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42043-262-38	ML - Milliliter	42043-262	d59fd459-ec00-44b9-a5b7-d84b5aa231c4	1	2015-10-02
42043-262-57	ML - Milliliter	42043-262	0879b84c-9dbd-4613-960d-46d57e364a6c	1	2015-10-02
42043-262-77	ML - Milliliter	42043-262	af7852cb-a81a-4ba5-ab36-b33e42737eba	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFPROZIL	ACTIVE INGREDIENT	4W0459ZA4V	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
CEFPROZIL ANHYDROUS	ACTIVE MOIETY	1M698F4H4E	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
ANHYDROUS TRISODIUM CITRATE	INACTIVE INGREDIENT	RS7A450LGA	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFPROZIL POWDER, FOR SUSPENSION [ORCHIDPHARMA INC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4W0459ZA4V	CEFPROZIL	121123-17-9	CEFPROZIL

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CEFPROZIL FOR ORAL SUSPENSION, USP	OrchidPharma Inc \| Orchid Pharma Ltd. \| Hospira Healthcare India Private Limited	2018-11-20	HUMAN PRESCRIPTION DRUG LABEL	4